A Commercial-Stage Moderna Debuts At J.P. Morgan
Executive Summary
Moderna has received $2.8bn for advance purchase agreements for its COVID-19 vaccine, with much more to follow. Management outlined some initial financial updates for investors.
You may also be interested in...
J.P. Morgan, Without The Parties, Reveals An Industry Ready To Get Down To Business
The virtual J.P. Morgan Healthcare meeting was missing the usual energy but still had substance.
Adolescent Recruitment For COVID-19 Vaccine Trials Is Worry For Operation Warp Speed
However, recruitment for adult trials remains robust, OWS’ Slaoui says.
Moderna Increases Minimum Supply Of Coronavirus Vaccine Doses For 2021
The company’s announcement that it would supply at least 600 million doses of mRNA-1273 came as US vaccination rates have fallen far short of expectations.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports